Medicare Enrolled
Dr. Mark Snowise, MD
Family Medicine · Lee, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Snowise from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Snowise?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Snowise
Dr. Mark Snowise is a family medicine specialist in Lee, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Snowise performed 2,483 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Snowise received a total of $2,601 from 29 pharmaceutical and/or device companies across 139 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Snowise is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 8% volume in MA
$2,601 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,483
Medicare services
Top 8% in MA for family medicine
Not available
Unique patients (not deduplicated)
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
779 | $66 | $250 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
235 | $135 | $175 |
| Annual depression screening | 214 | $19 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
179 | $94 | $300 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $36 | $100 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
142 | $1 | $6 |
| Annual alcohol misuse screening, 5 to 15 minutes | 120 | $19 | $35 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
107 | $31 | $33 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
97 | $72 | $125 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
79 | $2 | $75 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
76 | $10 | $60 |
| Virtual check-in for established patient A brief communication service provided by a qualified healthcare professional to an established patient via technology, such as a virtual check-in. |
68 | $11 | $75 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
38 | $3 | $10 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
38 | $84 | $110 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
36 | $83 | $150 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
23 | $47 | $135 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
23 | $35 | $75 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $84 | $200 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
14 | $15 | $45 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
12 | $34 | $40 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
11 | $97 | $245 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 11 | $20 | $37 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
11 | $170 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$2,601
Total received (2018-2024)
Avg $372/year across 7 years
Top 9% in MA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
139
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$354
2023
$642
2022
$451
2021
$407
2020
$236
2019
$270
2018
$241
Payments by company (2024)
Otsuka America Pharmaceutical, Inc.
$50
Lilly USA, LLC
$50
Novo Nordisk Inc
$45
Abbott Laboratories
$42
Neurocrine Biosciences, Inc.
$39
GlaxoSmithKline, LLC.
$31
Sumitomo Pharma America, Inc.
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
PFIZER INC.
$16
ABBVIE INC.
$14
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 40.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$331
GlaxoSmithKline, LLC.
$241
PFIZER INC.
$216
Janssen Pharmaceuticals, Inc
$212
Boehringer Ingelheim Pharmaceuticals, Inc.
$179
Otsuka America Pharmaceutical, Inc.
$146
E.R. Squibb & Sons, L.L.C.
$137
Merck Sharp & Dohme Corporation
$123
Novo Nordisk Inc
$114
Lilly USA, LLC
$107
Merck Sharp & Dohme LLC
$85
Amgen Inc.
$81
Novartis Pharmaceuticals Corporation
$76
Abbott Laboratories
$60
Lundbeck LLC
$57
Sumitomo Pharma America, Inc.
$56
Nestle HealthCare Nutrition Inc.
$48
AbbVie Inc.
$47
ABBVIE INC.
$43
Astellas Pharma US Inc
$40
Neurocrine Biosciences, Inc.
$39
Seqirus USA Inc
$32
UCB, Inc.
$30
Amarin Pharma Inc.
$23
Philips Electronics North America Corporation
$21
Mylan Specialty L.P.
$18
Scilex Pharmaceuticals Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$13
Bioventus LLC
$11
Top 3 companies account for 30.3% of all-time payments
Associated products mentioned in payments ›
(5561) Software · ANORO · AREXVY · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · DIFICID · Durolane · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FREESTYLE LIBRE 3 · Fluad · Fluad Quadrivalent · GARDASIL · GARDASIL 9 · GEMTESA · INGREZZA · INVOKANA · JANUVIA · JARDIANCE · MOUNJARO · MYRBETRIQ · Nayzilam · Otezla · Ozempic · PNEUMOVAX 23 · PREMARIN · PREVNAR 13 · Prolia · QULIPTA · REXULTI · Rybelsus · SHINGRIX · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SYMBICORT · TRELEGY ELLIPTA · Trintellix · UBRELVY · Vascepa · Veozah · Victoza · XARELTO · Yupelri · ZENPEP · ZEPBOUND · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
53
County median income
$72,565
Nearest hospital to ZIP centroid (approximate)
FAIRVIEW HOSPITAL
10.0 mi
10.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Snowise is a clinical cardiology specialist, with above-average Medicare volume (top 8% in MA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Snowise experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Snowise performed 779 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Snowise receive payments from pharmaceutical companies?
Yes. Dr. Snowise received a total of $2,601 from 29 companies across 139 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Snowise's costs compare to other family medicine physicians in Lee?
Dr. Snowise's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Snowise) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Lee
Browse family medicine physicians in Lee ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in MA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in MA
Which MA family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology